# Platelet Rich Plasma (PRP) as Terapeutical Option in Erectil Disfunction (DE)

> **NCT06768177** · NA · ENROLLING_BY_INVITATION · sponsor: **Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari** · enrollment: 60 (estimated)

## Conditions studied

- Erectile Dysfunction Due to General Medical Condition
- Erectile Dysfunction Following Radical Prostatectomy
- Erectile Dysfunction Associated With Type 2 Diabetes Mellitus
- Erectile Dysfunctions

## Interventions

- **DRUG:** PRP injection
- **DRUG:** Alprostadil 20 micrograms

## Key facts

- **NCT ID:** NCT06768177
- **Lead sponsor:** Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2023-04-01
- **Primary completion:** 2024-11-01
- **Final completion:** 2025-11-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-10-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06768177

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06768177, "Platelet Rich Plasma (PRP) as Terapeutical Option in Erectil Disfunction (DE)". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT06768177. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*